Advances in mechanisms of repair and remodelling in acute lung injury
- PMID: 18264692
- DOI: 10.1007/s00134-007-0963-x
Advances in mechanisms of repair and remodelling in acute lung injury
Abstract
Background: Acute respiratory distress syndrome (ARDS) is the most severe manifestation of acute lung injury (ALI). In patients who survive the acute injury the process of repair and remodelling may be an independent risk factor determining morbidity and mortality. This review explores recent advances in the field of fibroproliferative ARDS/ALI, with a special emphasis on (a) the primary contributing factors with a focus on cellular and soluble factors, and (b) mechanisms involved in repair and remodelling as they pertain to the importance of cell death, re-population, and matrix deposition.
Discussion: Factors influencing progression to fibroproliferative ARDS vs. resolution and reconstitution of the normal pulmonary parenchymal architecture are poorly understood. Determinants of persistent injury and abnormal repair and remodelling may be profoundly affected by both environmental and genetic factors. Moreover, cumulative evidence suggests that acute inflammation and fibrosis may be in part independent and interactive processes that are autonomously regulated and thus amenable to individual and specific therapy.
Conclusions: Although our current understanding of these processes is limited by the inability to accurately replicate the complex human physiology in laboratory settings, it has recently become apparent that the process of repair and remodelling begins early in the course of ARDS/ALI and may be determined by the type of pulmonary injury. Understanding the mechanisms leading to and regulating fibroproliferative changes may contribute to the development of novel early therapeutic interventions in ARDS/ALI patients.
Similar articles
-
Lung parenchyma remodeling in acute respiratory distress syndrome.Minerva Anestesiol. 2009 Dec;75(12):730-40. Minerva Anestesiol. 2009. PMID: 19940826 Review.
-
The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.Eur Respir J. 2014 Jan;43(1):276-85. doi: 10.1183/09031936.00196412. Epub 2013 Mar 21. Eur Respir J. 2014. PMID: 23520315 Free PMC article. Review.
-
Mechanisms of alveolar epithelial repair in acute lung injury--a translational approach.Swiss Med Wkly. 2003 Nov 22;133(43-44):586-90. doi: 10.4414/smw.2003.10267. Swiss Med Wkly. 2003. PMID: 14745653 Review.
-
Animal models of fibrotic lung disease.Am J Respir Cell Mol Biol. 2013 Aug;49(2):167-79. doi: 10.1165/rcmb.2013-0094TR. Am J Respir Cell Mol Biol. 2013. PMID: 23526222 Free PMC article. Review.
-
Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S367-78. doi: 10.1038/sj.bjp.0707603. Epub 2008 Jan 28. Br J Pharmacol. 2008. PMID: 18223674 Free PMC article. Review.
Cited by
-
RGD-binding integrins and TGF-β in SARS-CoV-2 infections - novel targets to treat COVID-19 patients?Clin Transl Immunology. 2021 Mar 18;10(3):e1240. doi: 10.1002/cti2.1240. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33747508 Free PMC article. Review.
-
Simulation of lung alveolar epithelial wound healing in vitro.J R Soc Interface. 2010 Aug 6;7(49):1157-70. doi: 10.1098/rsif.2010.0041. Epub 2010 Mar 17. J R Soc Interface. 2010. PMID: 20236957 Free PMC article.
-
Compositional changes of the lung extracellular matrix in acute respiratory distress syndrome.Am J Physiol Cell Physiol. 2025 Apr 1;328(4):C1279-C1292. doi: 10.1152/ajpcell.01007.2024. Epub 2025 Mar 10. Am J Physiol Cell Physiol. 2025. PMID: 40063067
-
Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis.Crit Care. 2014 Apr 7;18(2):R63. doi: 10.1186/cc13819. Crit Care. 2014. PMID: 24708846 Free PMC article.
-
Houttuynia cordata inhibits lipopolysaccharide-induced rapid pulmonary fibrosis by up-regulating IFN-γ and inhibiting the TGF-β1/Smad pathway.Int Immunopharmacol. 2012 Jul;13(3):331-40. doi: 10.1016/j.intimp.2012.03.011. Epub 2012 May 2. Int Immunopharmacol. 2012. PMID: 22561446 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical